Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo.

Gaglione, S. A., Mukkamala, R. S., Krishna, C., Smith, B. E., Wadsworth, M. H., Jelinsky, S. A., Perez, C. R., Schmidt-Hong, L., Katz, E. L., Gellatly, K. J., Ali, L. R., Shen, J., Holec, P. , V, Zhao, Q. H., Chan, A. O., Xu, E. J. K., Kravarik, K. M., Guzova, J. A., Dobson, C. S., … Birnbaum, M. E. (2026). Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo.. Immunity, 59(2), 477-493.e9.

Abstract

T cells initiate targeted immune responses using T cell receptors (TCRs) to recognize specific antigens. Mapping TCRs to antigens at scale remains a major challenge. Here, we developed an approach to synthesize and functionally screen tens of thousands of TCRs simultaneously. TCR rapid assembly for functional testing (TCRAFT) uses a modular strategy to rapidly and inexpensively construct large pools of TCRs from sequences while maintaining TCRα/β pairing. We applied TCRAFT to reconstruct over 3,800 TCRs from vitiligo blister fluid and mapped these TCRs to specific peptide-major histocompatibility complexes using RAPTR, an activation-based library-on-library screening approach. Vitiligo antigen-specific T cells displayed pronounced clonal expansion and transcriptomic signatures similar to antigen-specific T cells in melanoma, pointing to shared features of disease-relevant T cells in autoimmunity and cancer. Demonstrating scalability, we synthesized and screened over 30,800 TCRs from donors with pancreatic ductal adenocarcinoma to capture antigen-reactive TCRs. Our approach expands the scale and accessibility of TCR-antigen screening, which is critical to understanding immunity and developing new immunotherapies.

Last updated on 04/01/2026
PubMed